Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Spine Surgery for Lenke 1 Adolescent Idiopathic Scoliosis

NCT06396286 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2024-06-12
Last updated
2025-12-30

Condition(s) studied

ScoliosisSpine DeformityAdolescent Idiopathic Scoliosis

Investigational drug(s) / intervention(s)

single rod

single rod: surgical correction of severe adolescent idiopathic scoliosis with screws and a single rod.

Study summary

Idiopathic scoliosis of developmental age (AIS) is the most vertebral deformity in the adolescent population, with a prevalence of 1-3%. The treatment of AIS depends on the morphology and extent of the curve and the growth potential residual, can range from simple clinical-radiological monitoring, to the use of braces to, in the most severe cases, correction surgical correction. The indication for surgical correction of AIS depends on the location, extent and flexibility of the scoliotic curve and not least on the patient's age or, better, the skeletal age. The primary goal of surgery is to correcting the deformity by preventing its progression, preserving as many motion segments as possible; secondarily, the surgery aims to restore the coronal and sagittal balance of the spine.

Eligibility

Sex
ALL
Min age
12 Years
Max age
21 Years
Healthy volunteers
No
INCLUSION CRITERIA: * Diagnosis of AIS; * Male and female sex; * Age between 12 and 21; * Thoracic scoliotic curve, type I according to Lenke's classification; * Preoperative radiographic range of the main scoliotic curve between 40° and 70° Cobb; * Reducibility of the curve on bending radiographs by 30%; * Signature of the informed consent of patients/parents to actively participate in the study and clinical follow-up. EXCLUSION CRITERIA: * Scoliosis with an etiology different from AIS; * pre-operative COBB \> 70°; * Patients already treated surgically for scoliosis; * Location of the scoliotic curve: Lenke 2-6; * Patients who do not fall within the parameters described; * Patients unable to express consent or carry out follow-ups; * Language barrier; * Pregnant women.

Primary outcome measure(s)

  • Spine Correction — at baseline
    The correction of the curvature of the back will be evaluated via x-ray
  • Spine Correction — at 12 months
    The correction of the curvature of the back will be evaluated via x-ray
  • Quality of Life 1 — at baseline
    The "Scoliosis Research Society 22" is a multidimensional questionnaire covering the four non-management domains of pain, function, self-image, and mental health (5 items per domain), along with 2 items to assess the patient's satisfaction with management of their deformity
  • Quality of Life 1 — at 12 months
    The "Scoliosis Research Society 22" is a multidimensional questionnaire covering the four non-management domains of pain, function, self-image, and mental health (5 items per domain), along with 2 items to assess the patient's satisfaction with management of their deformity
  • Quality of Life 2 — at baseline
    The Oswestry Disability Index (ODI) a patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from back pain.
  • Quality of Life 2 — at 12 months
    The Oswestry Disability Index (ODI) a patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from back pain.

Trial sites (1)

FacilityCityRegionStatus
Istituto Ortopedico Rizzoli Bologna Italy
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06396286 on ClinicalTrials.gov ↗ ← All trials in Italy